Pieris Pharma (PIRS) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts PIRS Hot Sheet
Join SI Premium – FREE
Pieris Pharma (NASDAQ: PIRS) reported Q3 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Pieris Pharma (PIRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
